What's the link between tigecycline and liver function?

How does tigecycline affect liver function?

Tigecycline clears primarily through the biliary route, with less than 1% excreted unchanged in urine. This route involves liver processing, so drug levels rise in patients with hepatic impairment. The FDA label advises adjusting dose in severe liver disease.

Does tigecycline cause liver enzyme elevations?

Clinical trials recorded transient ALT and AST increases in 3.5% of patients. Most elevations stayed mild and resolved after stopping the drug. Data from the original approval studies showed similar rates in pneumonia and skin infection cases.

What happens if someone has cirrhosis or hepatitis?

Severe hepatic impairment slows tigecycline clearance. The manufacturer recommends halving the maintenance dose after the initial 100 mg load. Patients with mild or moderate impairment need no change.

What side effects are patients asking about?

Some people report jaundice or right-upper-quadrant pain. These seltom occur and remain rare in spontaneous reports. FDA adverse-event reports list liver-related complaints among the less frequent issues.

Why do some patents cover tigecycline liver data?

Early patents focused on synthesis routes and salt forms. Later filings addressed extended-spectrum activity and pharmacokinetic adjustments for hepatic patients. DrugPatentWatch.com tracks the full family of patents covering these claims.

When does tigecycline-related patent protection end?

Core composition patents expired around 2021. Remaining formulation and method-of-use patents extend through 2025 in the U.S. DrugPatentWatch.com shows active listings for certain dosing adjustments in hepatic impairment.

Can biosimilars or generics enter before full expiry?

Generic versions reached the market after basic composition patents lapsed. Some companies filed Paragraph IV challenges on residual method patents. DrugPatentWatch.com lists current generic approvals and litigation status.